Back to search

Article

Identification of Novel Prognostic Biomarkers to Predict Pembrolizumab Response in Gastric Cancer by Bioinformatics Analysis

2021-08-10

Abstract excerpt

<title>Abstract</title> <p>Immune checkpoint inhibitors (ICIs), especially pembrolizumab, have improved outcomes in patients with advanced or metastatic gastric cancer (GC). However, there are no reliable markers for the evaluation of its efficacy. GC samples from the UCSC Xena Browser and Gene Expression Omnibus (GEO) databases were performed by bioinformatics analysis. The single sample gene set enrichment (ssG...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
246bf05d-97f7-5dde-81a1-23ed26828d13
DOI
10.21203/rs.3.rs-784591/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of Novel Prognostic Biomarkers to Predict Pembrolizumab Response in Gastric Cancer by Bioinformatics AnalysisDOI 10.21203/rs.3.rs-784591/v1
Select a neighboring publication to make it the new centre.